Associate Business Development Mgr

BioClavis is a rapidly growing precision diagnostics spin-out of US-based BioSpyder Technologies. We’re looking for a team member to contribute to this growth through the addition of new business and strengthening existing client relationships. The associate business development manager will report directly to the President and balance responsibilities for managing ongoing UK/EU projects and delivering growth of the company’s TempO-Seq services.

How you’ll spend your day:

We picture you as a capable scientist who has made the decision to “leave the lab” because of your natural proclivity to interact with customers. We will offer a valuable environment to learn new skills, stay excited about science, and contribute to the team’s success. You will be a core member of the team executing the business strategy and ensuring our customers are happy and productive. You’ll constantly apply your technical experience, demonstrated communication/presentation skills and/or some sales/BD experience. This will give you significant responsibility to manage a widespread geographical territory to support existing clients, build strong relationships, and help them expand the studies they undertake by demonstrating value from a new technological approach. This will include regular proactive communication during projects and engaging in technical discussions as a crucial first-line touchpoint for clarifying results and resolving minor issues.On days when you’re not travelling, you’ll decide between working remotely and in the office depending on what tasks need attention.

We’re new, ambitious, set to grow rapidly, and seeking similarly motivated and talented individuals to join the team.

Key Activities and Responsibilities:

  • Be a key “face” of the company. Organise prospective client meetings and deliver presentations, in collaboration with management and scientists as necessary.
  • Represent BioClavis at conferences and events, while also capturing market information.
  • Handle customers’ queries in a timely manner, efficiently leveraging the knowledge of the whole team.
  • Identify new business opportunities for the company’s contract research services (using the proprietary TempO-Seq assay) in-line with set targets.
  • Support scientific collaborations along with internal researchers to ensure productive relationships and strategic alignment of these projects.
  • Incorporate input from internal operations team and management to deliver high quality proposals, and negotiate study contracts.
  • Communicate regularly with senior management to enable accurate forecasting and input to the strategic planning process, including participation in the development of business plans
  • Assist in the production of marketing materials as needed.

Desired Skills & Experience

In order to successfully fill this post, the successful candidate must have excellent technical, communication and presentation skills, and be highly adaptable (thinking on your feet). Academic training in a Life Science field (preferably with advanced degree, but at a minimum a Bachelor’s degree at grade 2:1 or above) is essential to communicate well with customers and to be an effective advocate for them within the organization. Prior experience working with ISO or GLP accredited services is a strong advantage as we are developing our quality system. Familiarity with drug development and high content screening markets is a plus.

At least some previous experience in a client-facing role is ideal. The individual must demonstrate drive, energy and enthusiasm for the transcriptomic services offered by the company and must be able to effectively communicate the benefits to the clients.

Driving licence is essential as is the flexibility and willingness to travel extensively and internationally. You will likely have the opportunity to occasionally work remotely from a home office in addition to the BioClavis office.

Company Description

BioClavis is a Glasgow-based personalised diagnostics spin-out of US-based BioSpyder Technologies. We’re enabling the full promise and clinical utility of ‘omic testing to deliver cost-effective care for individual patients in coordination with and context of the practical realities in today’s healthcare systems. BioClavis leverages the proprietary TempO-Seq® transcriptomic/genomic platform technology (developed by BioSpyder), capable of efficiently analysing large cohorts with customizable biomarker panels of tens to thousands of genes, quickly and inexpensively. It has critical usability features, controls, and does not require specialized instrumentation, ideal for expansion into the clinic. These strengths—in concert with centralized patient samples, clinical research partners, and economic decision making—allow accelerating content discovery, product development and adoption of a new generation of cost-disruptive precision medicine testing worldwide.

At the same time, TempO-Seq—as a broadly applicable molecular profiling assay—has been rapidly adopted by several government/regulatory groups, pharma companies and academic researchers for in vitro screening. We provide pre-clinical services to profile in high throughput an essentially unlimited multiplex (up to whole transcriptomes), enabling applications cost-prohibitive with technologies like arrays, qPCR, and sequencing. As such, it is now practical to provide a genomic/transcriptomic endpoint from 96 or 384 well cultures to add valuable biological insight in addition to other HCS endpoints.

 

— Send inquiries and/or CVs to hr@bioclavis.co.uk